Regeneron Pharmaceuticals, Inc. (REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The results exceeded analysts’ expectations.
The company is advancing REGN-COV2, a novel investigational antibody “cocktail” treatment designed to prevent and treat the...
I'm doing some pro-bono research and consulting on the questions below regarding Roche SARS-CoV-2 Test for COVID-19. I AM NOT consulting or working for Roche!
Has a cost or price been established for this test (lab &/or patient)?
How many cobas® 6800 and cobas® 8800 Systems are installed in...